Screener
Lexaria Bioscience LEXX Q2 2025 earnings
Reported July 14, 2025 · Before market open
Revenue$174.0KBeat by $37.0K
EPS-$0.21Miss by $0.06
Revenue estimate$137.0K
EPS estimate-$0.15
Next report
Oct 28, 2026 (in 2 months)Revenue estimate$50.0K
EPS estimate-$0.90
Versus estimates
Revenue
Q1 2026$20.0KMiss by $30.0KQ3 2025$174.0KBeat by $37.0K
Q2 2025$174.0KBeat by $37.0K
Q1 2025$174.0KBeat by $82.7KDiluted EPS
FAQ
- When did Lexaria Bioscience report Q2 2025 earnings?
- Lexaria Bioscience (LEXX) reported Q2 2025 earnings on July 14, 2025 before market open.
- What were Lexaria Bioscience's Q2 2025 revenue and EPS?
- Lexaria Bioscience reported revenue of $174.0K and eps of $-0.21 for Q2 2025.
- Did Lexaria Bioscience beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $137.0K by $37.0K. EPS missed the consensus estimate of $-0.15 by $0.06.
- How did Lexaria Bioscience's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 107.1% from $84.0K a year earlier and eps declined 61.5% from $-0.13.
- Where can I find Lexaria Bioscience's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001640334-25-001195) directly on SEC EDGAR. The filing index links above go to sec.gov.
